Spots Global Cancer Trial Database for pulmonary carcinoid tumor
Every month we try and update this database with for pulmonary carcinoid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs | NCT04915144 | Neuroendocrine ... Carcinoid Tumor Pulmonary Carci... Gastroenteropan... Vipoma Insulinoma Gastrinoma | 177Lu-DOTATOC | 19 Years - | British Columbia Cancer Agency | |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Solid Tumors | NCT00003565 | Bladder Cancer Breast Cancer Head and Neck C... Lung Cancer Unspecified Adu... | docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors | NCT00227617 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... Neuroendocrine ... | bevacizumab 5-fluorouracil leucovorin oxaliplatin | 18 Years - | University of California, San Francisco | |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers | NCT00900419 | Esophageal Canc... Head and Neck C... Lung Cancer Precancerous Co... | immunohistochem... laboratory biom... sputum cytology biopsy | 21 Years - 90 Years | University of Colorado, Denver | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors | NCT02259725 | Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Somatostatinoma | regorafenib laboratory biom... | 18 Years - | University of Southern California | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | NCT00024076 | Lung Cancer Malignant Mesot... Metastatic Canc... Thymoma and Thy... | radiofrequency ... | - | Jonsson Comprehensive Cancer Center | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma | NCT00093782 | Metastatic Gast... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... | temsirolimus laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease | NCT00733252 | Lung Cancer Malignant Mesot... Metastatic Canc... Nonmalignant Ne... Precancerous Co... | bronchoscopic a... diagnostic bron... histopathologic... optical coheren... | - | Case Comprehensive Cancer Center | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | NCT00019331 | Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu... | aldesleukin ras peptide can... sargramostim DetoxPC | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | NCT00002470 | Gastrointestina... Lung Cancer | recombinant int... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| DNA Analysis of Blood and Tissue From Patients With Lung Cancer | NCT00471978 | Lung Cancer | 18 Years - 120 Years | Massachusetts General Hospital | ||
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | NCT00002470 | Gastrointestina... Lung Cancer | recombinant int... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors | NCT02259725 | Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Somatostatinoma | regorafenib laboratory biom... | 18 Years - | University of Southern California | |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | NCT00006368 | Brain and Centr... Breast Cancer Gastrointestina... Islet Cell Tumo... Lung Cancer Lymphoma Melanoma (Skin) Neoplastic Synd... | yttrium Y 90-ed... | 18 Years - | Novartis | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | NCT00084461 | Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Regional Gastro... Somatostatinoma | romidepsin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs | NCT04915144 | Neuroendocrine ... Carcinoid Tumor Pulmonary Carci... Gastroenteropan... Vipoma Insulinoma Gastrinoma | 177Lu-DOTATOC | 19 Years - | British Columbia Cancer Agency | |
| Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer | NCT00096083 | Cancer | isolated perfus... melphalan | 16 Years - | Delcath Systems Inc. | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | NCT00084461 | Gastrinoma Glucagonoma Insulinoma Metastatic Gast... Pancreatic Poly... Pulmonary Carci... Recurrent Gastr... Recurrent Islet... Regional Gastro... Somatostatinoma | romidepsin laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
